Vernakalant in the management of atrial fibrillation.

Vernakalant in the management of atrial fibrillation.

Item
http://www.wikidata.org/entity/Q37107714
Meta-analysis of effect of vernakalant on conversion of atrial fibrillation.Medication management of atrial fibrillation: emerging therapies for rhythm control and stroke prevention.Costs and clinical consequences of suboptimal atrial fibrillation management.Drug therapy in atrial fibrillation management: where do we stand in 2010?The emerging role of antiarrhythmic compounds with atrial selectivity in the management of atrial fibrillation.Management of atrial fibrillation in patients with heart failure: from drug therapy to ablation.Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.Vernakalant (RSD1235) in the management of atrial fibrillation: a review of pharmacological properties, clinical efficacy and safety.The pharmaceutical pipeline for atrial fibrillation.Update on the clinical management of atrial fibrillation: guidelines and beyond.Vernakalant hydrochloride for the treatment of atrial fibrillation.
P2860

Vernakalant in the management of atrial fibrillation.

Item
http://www.wikidata.org/entity/Q37107714
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vernakalant in the management of atrial fibrillation.
@en
Vernakalant in the management of atrial fibrillation.
@nl
type
label
Vernakalant in the management of atrial fibrillation.
@en
Vernakalant in the management of atrial fibrillation.
@nl
prefLabel
Vernakalant in the management of atrial fibrillation.
@en
Vernakalant in the management of atrial fibrillation.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Vernakalant in the management of atrial fibrillation.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921